CD8A and posterior cortical atrophy: ADT increases both CD8+ T-cells and Tregs in the TME; the degree of infiltration of CCR4+ Tregs is related to the prognosis of PCa patients, suggesting that a combination of Treg-depleting agents may improve the efficacy of ADT for the treatment of advanced PCa [58,60].